Nippon Shinyaku Company Description

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements.

The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis.

Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

Nippon Shinyaku Co., Ltd.

Country	Japan
Founded	1911
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,243
CEO	Toru Nakai

Contact Details

Address: 14, Nishinosho-Monguchi-cho Kyoto, 601-8550 Japan
Phone	81 7 5321 1111
Website	nippon-shinyaku.co.jp

Stock Details

Ticker Symbol	4516
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3717600005
SIC Code	2834

Key Executives

Name	Position
Toru Nakai	Chief Executive Officer
Hideyuki Fujii	Chief Financial Officer